CTRI/2010/091/001160已完成4 期
Post marketing surveillance for evaluation of efficacy and safety of vitamin c 15% w/w in melasma
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Cipla Ltd
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Written informed consent
- •2.Subjects of either sex 18 years and above
- •3.Subjects with diagnosis of Facial Melasma
- •4.In the opinion of the investigator, able to comply with the requirements of the protocol.
排除标准
- •1.Subjects hypersensitive to any of the component of the investigational product
- •2.Judged by Investigator to be inappropriate as subjects
研究者
相似试验
已完成
4 期
This is an observational study to determine the efficacy and safety of vitamin-c in facial photodamageCTRI/2010/091/001161Cipla Ltd24
已完成
4 期
A post-marketing study of the marketed product Maxtra® P syrup for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031189Zuventus Healthcare Limited200
已完成
4 期
A post-marketing study of the marketed product Maxtra® P Tablets for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031390Zuventus Healthcare Limited200
尚未招募
4 期
A post-marketing surveillance for the Evaluation of the safety of TGlobulin25 for the induction of immunosuppressive therapy in adult kidney transplant candidatesIRCT20201230049888N1Kawsar biotech company100
已完成
4 期
Phase IV Clinical Trial to Evaluate the Efficacy and Safety of basic Fibroblast Growth Factor Compared to Placebo in Combination with NBUVB for the Treatment of VitiligoIRCT20201104049265N1Imen Vaccine Alborz88